FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

GE Nuclear Medicine System Recall is Class 1

FDA says the GE Healthcare 12/19/22 recall of nuclear medicine systems is Class 1.

latest-news-card-1
Human Drugs

Eiger Wont Seek EUA for Interferon Covid Treatment: Bloomberg

Bloomberg reports that experts are debating the value of therapeutics like Eigers lambda peginterferon against Covid.

latest-news-card-1
Human Drugs

Eylea Approved for Infants with Retinopathy

FDA approves Regeneron Pharmaceuticals Eylea (aflibercept) injection to treat preterm infants with retinopathy of prematurity.

latest-news-card-1
Medical Devices

FDA Updates Philips MDRs; 82 Deaths in 2 Months

FDA updates an ongoing safety communication on Philips Respironics ventilators, BiPAP machines, and CPAP machines to provide information about medical...

latest-news-card-1
Medical Devices

FDA Denies DuraSeal Spinal Sealant Petition

FDA denies all requests in a 2013 petition seeking action against DuraSeals Spinal Sealant.

latest-news-card-1
Human Drugs

DoJ Wants Conspiracy Charge Against KVK-Tech

Courthouse News Service says the Justice Department has asked the 3rd Circuit Court of Appeals to reinstate conspiracy charges against KVK-Tech, a New...

latest-news-card-1
Human Drugs

FDA Revises Guidance on Compounding Ibuprofen

FDA revises its guidance on compounding certain ibuprofen oral suspension products to address ongoing product shortages.

latest-news-card-1
Federal Register

Regulatory Review Periods for Erleada and Xospata

Federal Register notice: FDA determines for patent term extension purposes the regulatory review periods for two drug products Janssens Erleada and A...

latest-news-card-1
Federal Register

Panel to Discuss Next Seasons Flu Shot

Federal Register notice: FDA announces a 3/7 Vaccines and Related Biological Products Advisory Committee meeting to discuss the flu vaccines strain se...

latest-news-card-1
Human Drugs

Senate Judiciary Committee Clears 5 Drug Bills

The Senate Judiciary Committee clears five drug-related bills that would prohibit brand manufacturers from blocking/delaying generic drug competition,...